drugset / Trial / NCT00517556

Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea

NCT00517556

Phase 1/2 Completed 38 enrolled Milton S. Hershey Medical Center
RandomizedParallel-groupSingle-blindTreatment

Summary

The primary hypothesis is that continuous administration of an OCP (CCOCP regimen) will result in more pain relief than a traditional 21/7 administration in primary dysmenorrhea (PD) patients.

Timeline

Start
2007-08
Primary completion
2011-03
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gestodene Small molecule 0.075 mg Oral
Comparator ethinyl estradiol Small molecule 20 ug Oral

Indications